Skip to content
Search

Latest Stories

Oxford experts on mission for Covid-19 app for instant contact tracing

A team of medical research and bioethics experts at Oxford University are supporting several European countries to explore the feasibility of a coronavirus mobile app for instant contact tracing.

If rapidly and widely deployed, the infectious disease experts believe such an app could significantly help to contain the spread of coronavirus.


The Oxford University team has provided European governments, including the UK, with evidence to support the feasibility of developing a contact tracing mobile app that is instant, could be widely deployed, and should be implemented with appropriate ethical considerations.

The team recommends that the mobile application should form part of an integrated coronavirus control strategy that identifies infected people and their recent person-to-person contacts using digital technology.

Professor Christophe Fraser from Oxford University’s Big Data Institute, Nuffield Department of Medicine, said traditional public health contact tracing methods are too slow to keep up with the virus.

“Coronavirus is unlike previous epidemics and requires multiple inter-dependent containment strategies. Our analysis suggests that almost half of coronavirus transmissions occur in the very early phase of infection, before symptoms appear, so we need a fast and effective mobile app for alerting people who have been exposed," he said.

Dr David Bonsall, researcher at Oxford’s Nuffield Department of Medicine and clinician at Oxford’s John Radcliffe Hospital, added that not everybody has to use the mobile app for it to work.

"If with the help of the app the majority of individuals self-isolate on showing symptoms, and the majority of their contacts can be traced, we stand a chance of stopping the epidemic," he said.

“To work, this approach needs to be integrated into a national programme, not taken on by independent app developers. If we can securely deploy this technology, the more people that opt-in, the faster the epidemic will stop, and the more lives can be saved.”

Professor Fraser’s team at the Big Data Institute are continuing to simulate performance of the application so it could be adjusted to include mobile app guided coronavirus testing, and or provide targeted responses in areas with particularly high rates of transmission.

Professor Fraser concludes:“Current strategies are not working fast enough to intercept transmission of coronavirus. To effectively tackle this pandemic we need to harness 21st century technology. Our research makes the case for a mobile application that accelerates our ability to trace infected people and provides vital information that keeps communities safe from this pandemic.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less